Sample classification from protein mass spectrometry, by 'peak probability contrasts'

被引:141
作者
Tibshirani, R [1 ]
Hastie, T
Narasimhan, B
Soltys, S
Shi, GY
Koong, A
Le, QT
机构
[1] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Stat, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
关键词
D O I
10.1093/bioinformatics/bth357
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Motivation: Early cancer detection has always been a major research focus in solid tumor oncology. Early tumor detection can theoretically result in lower stage tumors, more treatable diseases and ultimately higher cure rates with less treatment-related morbidities. Protein mass spectrometry is a potentially powerful tool for early cancer detection. We propose a novel method for sample classification from protein mass spectrometry data. When applied to spectra from both diseased and healthy patients, the 'peak probability contrast' technique provides a list of all common peaks among the spectra, their statistical significance and their relative importance in discriminating between the two groups. We illustrate the method on matrix-assisted laser desorption and ionization mass spectrometry data from a study of ovarian cancers. Results: Compared to other statistical approaches for class prediction, the peak probability contrast method performs as well or better than several methods that require the full spectra, rather than just labelled peaks. It is also much more interpretable biologically. The peak probability contrast method is a potentially useful tool for sample classification from protein mass spectrometry data.
引用
收藏
页码:3034 / 3044
页数:11
相关论文
共 27 条
[1]  
ADAM B.L, 2003, CANCER RES, V63, P3609
[2]  
Benjamini Y., 1985, J ROYAL STAT SOC B, V57, P289
[3]  
Breiman L., 1998, CLASSIFICATION REGRE
[4]   Empirical Bayes methods and false discovery rates for microarrays [J].
Efron, B ;
Tibshirani, R .
GENETIC EPIDEMIOLOGY, 2002, 23 (01) :70-86
[5]  
Efron B., 2002, LEAST ANGLE REGRESSI
[6]   Disease proteomics [J].
Hanash, S .
NATURE, 2003, 422 (6928) :226-232
[7]   TUMOR-MARKERS IN PATIENTS WITH LUNG-CANCER [J].
HANSEN, M ;
PEDERSEN, AG .
CHEST, 1986, 89 (04) :S219-S224
[8]   NEW DESORPTION STRATEGIES FOR THE MASS-SPECTROMETRIC ANALYSIS OF MACROMOLECULES [J].
HUTCHENS, TW ;
YIP, TT .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 1993, 7 (07) :576-580
[9]  
Klade CS, 2001, PROTEOMICS, V1, P890, DOI 10.1002/1615-9861(200107)1:7<890::AID-PROT890>3.3.CO
[10]  
2-Q